Effects of hypoxia-inducible factor-prolyl hydroxylase inhibitors vs. erythropoiesis-stimulating agents on iron metabolism in non-dialysis-dependent anemic patients with CKD: A network meta-analysis

OBJECTIVE: To compare the effects of five hypoxia-inducible factor-prolyl hydroxylase domain inhibitors (HIF-PHIs), two erythropoiesis-stimulating agents (ESAs), and placebo on iron metabolism in renal anemia patients with non-dialysis-dependent chronic kidney disease (NDD-CKD). METHOD: Five electro...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Junlan, Xing, Jie, Zhu, Xiaodong, Xie, Xiaotong, Wang, Lina, Zhang, Xiaoliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060950/
https://www.ncbi.nlm.nih.gov/pubmed/37008953
http://dx.doi.org/10.3389/fendo.2023.1131516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060950/
https://www.ncbi.nlm.nih.gov/pubmed/37008953
http://dx.doi.org/10.3389/fendo.2023.1131516

Ejemplares similares